scholarly article | Q13442814 |
P356 | DOI | 10.1002/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N |
P698 | PubMed publication ID | 11315914 |
P50 | author | Jacob K. Sont | Q37381820 |
P2093 | author name string | Breedveld FC | |
van Laar JM | |||
van de Putte LB | |||
Bijlsma JW | |||
Fibbe WE | |||
Kruize AA | |||
van den Hoogen FH | |||
Verburg RJ | |||
Barge RM | |||
Preijers F | |||
Petersen EJ | |||
P433 | issue | 4 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
stem cell transplantation | Q65592366 | ||
P304 | page(s) | 754-760 | |
P577 | publication date | 2001-04-01 | |
P1433 | published in | Arthritis and Rheumatism | Q23929027 |
P1476 | title | High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy | |
P478 | volume | 44 |
Q40498732 | A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation |
Q63214396 | Autologous hematopoietic stem cell transplantation for autoimmune diseases |
Q35554404 | Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry |
Q36401901 | Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study |
Q73895232 | Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma |
Q35547252 | Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders |
Q34017756 | Hematopoietic cell transplantation for Crohn's disease; is it time? |
Q26751425 | Hematopoietic stem cell transplantation for auto immune rheumatic diseases |
Q35204112 | Hematopoietic stem cell transplantation for severe rheumatoid arthritis |
Q34744649 | High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. |
Q34606571 | High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases |
Q24798777 | Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia |
Q94672685 | Looking for immortality: Review of phytotherapy for stem cell senescence |
Q41869348 | Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration |
Q74248344 | Pharmacoepidemiology and drug safety |
Q35091598 | Prevalence of anti-citrullinated protein antibodies (ACPA) in patients with diffuse large B-cell lymphoma (DLBCL): a case-control study |
Q37607071 | Regulatory T cells as therapeutic targets in rheumatoid arthritis |
Q42224815 | Stem cell therapy: resetting autoimmunity or postponing the inevitable? |
Q35558523 | Stem cell transplantation for multiple sclerosis: What is the evidence? |
Q36993217 | Stem cell transplantation for rheumatic autoimmune diseases |
Q37586832 | Targeted therapies in rheumatoid arthritis: Focus on rituximab. |
Q36352913 | Therapies for rheumatoid arthritis: hope springs eternal |